Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study

被引：0
|
作者：
Jeeyun Lee
Kyung Hae Jung
Young Suk Park
Joong Bae Ahn
Sang Jun Shin
Seock-Ah Im
Do Youn Oh
Dong Bok Shin
Tae Won Kim
Namsu Lee
Jae Ho Byun
Yong Sang Hong
Joon Oh Park
Se Hoon Park
Ho Yeong Lim
Won Ki Kang
机构：
[1] Sungkyunkwan University School of Medicine,Division of Hematology
[2] Research Institute and Hospital,Oncology, Department of Medicine, Samsung Medical Center
[3] Yonsei University College of Medicine,Center for Colorectal Cancer, National Cancer Center
[4] Seoul National University College of Medicine,Department of Internal Medicine
[5] Gachon University Gil Medical Center,Department of Internal Medicine
[6] University of Ulsan College of Medicine,Division of Hematology and Oncology, Department of Internal Medicine
[7] Soon Chun Hyang University Hospital,Division of Oncology, Department of Medicine, Asan Medical Center
[8] The Catholic University of Korea,Division of Hematology
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Statin; Simvastatin; Irinotecan; Cetuximab; Lovastatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：657 / 663
页数：6
相关论文
共 50 条
  • [41] FOLFIRI plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC-03 multicenter phase II study
    Kochi, Mitsugu
    Akiyama, Yuji
    Aoki, Tatsuya
    Hagiwara, Ken
    Takahashi, Takao
    Hironaka, Katsuji
    Teranishi, Futoshi
    Osuka, Fumihiko
    Takeuchi, Masahiro
    Fujii, Masashi
    Nakajima, Toshifusa
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (05) : 1097 - 1102
  • [42] Multicenter phase II study of irinotecan plus bolus fluorouracil/l-leucovorin for metastasic colorectal cancer
    Mishima, Hideyuki
    Ikenaga, Masakazu
    Ishida, Hideyuki
    Iwamoto, Shigenori
    Morimoto, Takashi
    Narahara, Hiroyuki
    Kato, Takeshi
    Tsujie, Masaki
    Kitai, Toshiyuki
    Fukunaga, Mutsumi
    Nakanish, Masayoshi
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    Taguchi, Tetsuo
    ANTICANCER RESEARCH, 2007, 27 (02) : 1003 - 1008
  • [43] Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis
    Liang Xiao-bo
    Hou Sheng-huai
    Li Yao-ping
    Wang Li-chun
    Zhang Xin
    Yang Jun
    CHINESE MEDICAL JOURNAL, 2010, 123 (22) : 3314 - 3318
  • [44] Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis
    Clarke, Stephen J.
    Yip, Sonia
    Brown, Chris
    van Hazel, Guy A.
    Ransom, David T.
    Goldstein, David
    Jeffrey, G. Mark
    Tebbutt, Niall C.
    Buck, Martin
    Lowenthal, Raymond M.
    Boland, Amy
    Gebski, Val
    Zalcberg, John
    Simes, R. John
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (12) : 1826 - 1836
  • [45] Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302)
    Lapeyre-Prost, Alexandra
    Pernot, Simon
    Sigrand, Julie
    Le Malicot, Karine
    Mary, Florence
    Aparicio, Thomas
    Dahan, Laetitia
    Caroli-Bosc, Francois-Xavier
    Lecomte, Thierry
    Doat, Solene
    Marthey, Lysianne
    Desrame, Jerome
    Lepage, Come
    Taieb, Julien
    CLINICAL COLORECTAL CANCER, 2020, 19 (04) : 285 - 290
  • [46] Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: A pilot study
    Kwon, Hyuk-Chan
    Oh, Sung Yong
    Lee, Suee
    Kim, Sung-Hyun
    Kim, Hyo-Jin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (46) : 6231 - 6235
  • [47] A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma
    Blanke, CD
    Haller, DG
    Benson, AB
    Rothenberg, ML
    Berlin, J
    Mori, M
    Hsieh, YC
    Miller, LL
    ANNALS OF ONCOLOGY, 2001, 12 (11) : 1575 - 1580
  • [48] A phase I trial of CPT-11 in combination with 5-fluorouracil plus leucovorin chemotherapy for patients with metastatic colorectal cancer
    Yamaguchi, Y
    Minami, K
    Kawabuchi, Y
    Emi, M
    HEPATO-GASTROENTEROLOGY, 2006, 53 (68) : 201 - 205
  • [49] Third-Line Chemotherapy with irinotecan plus 5-Fluorouracil in Caucasian Metastatic Gastric Cancer Patients
    Pasquini, Giulia
    Vasile, Enrico
    Caparello, Chiara
    Vivaldi, Caterina
    Musettini, Gianna
    Lencioni, Monica
    Petrini, Lacopo
    Fornaro, Lorenzo
    Falcone, Alfredo
    ONCOLOGY, 2016, 91 (06) : 311 - 316
  • [50] Bevacizumab plus infusional 5-fluorouracil,leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy:A pilot study
    Hyuk-Chan Kwon
    Sung Yong Oh
    Suee Lee
    Sung-Hyun Kim
    Hyo-Jin Kim
    World Journal of Gastroenterology, 2007, (46) : 6231 - 6235
12345